The relationship between microRNAs and in-stent restenosis of coronary artery

Status

Active, not recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-OCH-14004263

Enrollment

Unknown

Registered

2014-02-12

Start date

2008-12-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

in-stent restenosis of coronary artery

Interventions

in-stent restenosis group and non in-stent resten:none

Eligibility

Sex/Gender

All

Age

35 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. patients received DES at the initial PCI; 2. follow-up coronary angiography at 6 to 12 months was performed; 3. patients received aspirin 100mg/day and clopidogrel 75 mg /day.

Exclusion criteria

Exclusion criteria: Patients with a total occluded artery or acute myocardial infarction were excluded

Design outcomes

Primary

Measure	Time frame
To observe the expression of microRNAs from plasma;	—

Countries

Chian

Contacts

Public ContactYue Li

the First Affiliated Hospital of Harbin Medical University

ly99ly@vip.163.com+86 13945057313

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026